Yipinhong announced that the innovative drug APH04935 tablets independently developed by Yipinhong Pharmaceutical, a wholly-owned subsidiary of the company, had previously obtained the “Drug Clinical Trial Approval Notice” from the China National Drug Administration; recently, the clinical trial application for the drug was approved by the US FDA and it was agreed to carry out clinical research in the US according to the submitted plan. The application number is IND 183306.

Zhitongcaijing · 2d ago
Yipinhong announced that the innovative drug APH04935 tablets independently developed by Yipinhong Pharmaceutical, a wholly-owned subsidiary of the company, had previously obtained the “Drug Clinical Trial Approval Notice” from the China National Drug Administration; recently, the clinical trial application for the drug was approved by the US FDA and it was agreed to carry out clinical research in the US according to the submitted plan. The application number is IND 183306.